Alerts will be sent to your verified email
Verify Email
None
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Speciality Medicines, incorporated in February 2021, is primarily focused on the export, trading, and distribution of pharmaceutical medicines and vaccines. The company is specialized in global supply of all medicinal products and a well-known distributor in the industry for providing quality rich, reliable services.
Speciality Medicines major competitors are Remus Pharmaceutical, Trident Lifeline, Mono Pharmacare.
Market Cap of Speciality Medicines is ₹0 Crs.
While the median market cap of its peers are ₹293 Crs.
Speciality Medicines seems to be less financially stable compared to its competitors.
Altman Z score of Speciality Medicines is 0 and is ranked 4 out of its 4 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
